984 related articles for article (PubMed ID: 28050651)
1. Primary transoral robotic surgery with concurrent neck dissection for early stage oropharyngeal squamous cell carcinoma implemented at a Danish head and neck cancer center: a phase II trial on feasibility and tumour margin status.
Rubek N; Channir HI; Charabi BW; Lajer CB; Kiss K; Nielsen HU; Bentzen J; Friborg J; von Buchwald C
Eur Arch Otorhinolaryngol; 2017 May; 274(5):2229-2237. PubMed ID: 28050651
[TBL] [Abstract][Full Text] [Related]
2. Selective neck dissection and deintensified postoperative radiation and chemotherapy for oropharyngeal cancer: a subset analysis of the University of Pennsylvania transoral robotic surgery trial.
Weinstein GS; Quon H; O'Malley BW; Kim GG; Cohen MA
Laryngoscope; 2010 Sep; 120(9):1749-55. PubMed ID: 20717944
[TBL] [Abstract][Full Text] [Related]
3. Long-term survival outcomes after primary transoral robotic surgery (TORS) with concurrent neck dissection for early-stage oropharyngeal squamous cell carcinoma.
Frederiksen JG; Channir HI; Larsen MHH; Christensen A; Friborg J; Charabi BW; Rubek N; von Buchwald C
Acta Otolaryngol; 2021 Jul; 141(7):714-718. PubMed ID: 34191671
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of transoral robotic surgery for early-stage oropharyngeal squamous cell carcinoma with low rates of adjuvant therapy: A consecutive single-institution study from 2013 to 2020.
Meldgaard Justesen M; Kronberg Jakobsen K; Fenger Carlander AL; Hjordt Holm Larsen M; Wessel I; Kiss K; Friborg J; Ibrahim Channir H; Rubek N; Grønhøj C; von Buchwald C
Oral Oncol; 2024 May; 152():106783. PubMed ID: 38569317
[TBL] [Abstract][Full Text] [Related]
5. A Phase 2 Trial of Alternative Volumes of Oropharyngeal Irradiation for De-intensification (AVOID): Omission of the Resected Primary Tumor Bed After Transoral Robotic Surgery for Human Papilloma Virus-Related Squamous Cell Carcinoma of the Oropharynx.
Swisher-McClure S; Lukens JN; Aggarwal C; Ahn P; Basu D; Bauml JM; Brody R; Chalian A; Cohen RB; Fotouhi-Ghiam A; Geiger G; Gershowitz J; Livolsi V; Mitra N; Montone K; Newman J; Ojerholm E; O'Malley B; Rajasekaran K; Tan E; Weinstein G; Lin A
Int J Radiat Oncol Biol Phys; 2020 Mar; 106(4):725-732. PubMed ID: 31785337
[TBL] [Abstract][Full Text] [Related]
6. Increase in primary surgical treatment of T1 and T2 oropharyngeal squamous cell carcinoma and rates of adverse pathologic features: National Cancer Data Base.
Cracchiolo JR; Baxi SS; Morris LG; Ganly I; Patel SG; Cohen MA; Roman BR
Cancer; 2016 May; 122(10):1523-32. PubMed ID: 26970050
[TBL] [Abstract][Full Text] [Related]
7. Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small-volume primary oropharyngeal carcinoma.
Howard J; Masterson L; Dwivedi RC; Riffat F; Benson R; Jefferies S; Jani P; Tysome JR; Nutting C
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD010963. PubMed ID: 27943254
[TBL] [Abstract][Full Text] [Related]
8. Oncological outcomes post transoral robotic surgery (TORS) for HPV-associated oropharyngeal squamous cell carcinoma, a single-centre retrospective Australian study.
Kornfeld B; Taha A; Kyang L; Sim HW; Dewhurst S; McCloy R; Chin V; Earls P; Parker A; Leavers B; Forstner D; Floros P; Crawford J; Gallagher R
J Robot Surg; 2024 May; 18(1):226. PubMed ID: 38806847
[TBL] [Abstract][Full Text] [Related]
9. Patterns of cervical node positivity, regional failure rates, and fistula rates for HPV+ oropharyngeal squamous cell carcinoma treated with transoral robotic surgery (TORS).
Cannon RB; Houlton JJ; Patel S; Raju S; Noble A; Futran ND; Parvathaneni U; Méndez E
Oral Oncol; 2018 Nov; 86():296-300. PubMed ID: 30409315
[TBL] [Abstract][Full Text] [Related]
10. Transoral robotic surgery-based therapy in patients with stage III-IV oropharyngeal squamous cell carcinoma.
Park YM; Kim HR; Cho BC; Keum KC; Cho NH; Kim SH
Oral Oncol; 2017 Dec; 75():16-21. PubMed ID: 29224814
[TBL] [Abstract][Full Text] [Related]
11. Making a case for high-volume robotic surgery centers: A cost-effectiveness analysis of transoral robotic surgery.
Rudmik L; An W; Livingstone D; Matthews W; Seikaly H; Scrimger R; Marshall D
J Surg Oncol; 2015 Aug; 112(2):155-63. PubMed ID: 26171771
[TBL] [Abstract][Full Text] [Related]
12. Early-stage squamous cell carcinoma of the oropharynx: radiotherapy vs. trans-oral robotic surgery (ORATOR)--study protocol for a randomized phase II trial.
Nichols AC; Yoo J; Hammond JA; Fung K; Winquist E; Read N; Venkatesan V; MacNeil SD; Ernst DS; Kuruvilla S; Chen J; Corsten M; Odell M; Eapen L; Theurer J; Doyle PC; Wehrli B; Kwan K; Palma DA
BMC Cancer; 2013 Mar; 13():133. PubMed ID: 23514246
[TBL] [Abstract][Full Text] [Related]
13. Outcomes in surgically resectable oropharynx cancer treated with transoral robotic surgery versus definitive chemoradiation.
Dhanireddy B; Burnett NP; Sanampudi S; Wooten CE; Slezak J; Shelton B; Shelton L; Shearer A; Arnold S; Kudrimoti M; Gal TJ
Am J Otolaryngol; 2019; 40(5):673-677. PubMed ID: 31201038
[TBL] [Abstract][Full Text] [Related]
14. Oncological outcome following de-intensification of treatment for stage I and II HPV negative oropharyngeal cancers with transoral robotic surgery (TORS): A prospective trial.
Dabas S; Gupta K; Ranjan R; Sharma AK; Shukla H; Dinesh A
Oral Oncol; 2017 Jun; 69():80-83. PubMed ID: 28559025
[TBL] [Abstract][Full Text] [Related]
15. The impact of transoral robotic surgery on the overall treatment of oropharyngeal cancer patients.
Smith RV; Schiff BA; Garg M; Haigentz M
Laryngoscope; 2015 Nov; 125 Suppl 10():S1-S15. PubMed ID: 26436491
[TBL] [Abstract][Full Text] [Related]
16. Comparative effectiveness trial of transoral head and neck surgery followed by adjuvant radio(chemo)therapy versus primary radiochemotherapy for oropharyngeal cancer (TopROC).
Bußmann L; Laban S; Wittekindt C; Stromberger C; Tribius S; Möckelmann N; Böttcher A; Betz CS; Klussmann JP; Budach V; Muenscher A; Busch CJ
BMC Cancer; 2020 Jul; 20(1):701. PubMed ID: 32727416
[TBL] [Abstract][Full Text] [Related]
17. Utility of up-front transoral robotic surgery in tailoring adjuvant therapy.
Gildener-Leapman N; Kim J; Abberbock S; Choby GW; Mandal R; Duvvuri U; Ferris RL; Kim S
Head Neck; 2016 Aug; 38(8):1201-7. PubMed ID: 27225507
[TBL] [Abstract][Full Text] [Related]
18. Management of Recurrent and Metastatic HPV-Positive Oropharyngeal Squamous Cell Carcinoma after Transoral Robotic Surgery.
Sims JR; Van Abel K; Martin EJ; Lohse CM; Price DL; Olsen KD; Moore EJ
Otolaryngol Head Neck Surg; 2017 Jul; 157(1):69-76. PubMed ID: 28374634
[TBL] [Abstract][Full Text] [Related]
19. Risk of Pathologic Extranodal Extension and Other Adverse Features After Transoral Robotic Surgery in Patients With HPV-Positive Oropharynx Cancer.
Zebolsky AL; George E; Gulati A; Wai KC; Carpenter P; Van Zante A; Ha PK; Heaton CM; Ryan WR
JAMA Otolaryngol Head Neck Surg; 2021 Dec; 147(12):1080-1088. PubMed ID: 34673904
[TBL] [Abstract][Full Text] [Related]
20. Functional outcomes, feasibility, and safety of resection of transoral robotic surgery: single-institution series of 35 consecutive cases of transoral robotic surgery for oropharyngeal squamous cell carcinoma.
Lörincz BB; Möckelmann N; Busch CJ; Knecht R
Head Neck; 2015 Nov; 37(11):1618-24. PubMed ID: 24955923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]